Quality of informed consent in cancer clinical trials in India: A cross-sectional survey
The National Medical Journal of India · 2018 · 31 (6) · 334
DOI: 10.4103/0970-258x.262900 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift The National Medical Journal of India, 2018. Verfasst von Vikram Gota und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Sector 22, Kharghar, Mumb…. Hauptthemen laut MEDLINE: Informed Consent, Physician-Patient Relations. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
Background
An 'informed consent' is a legal and ethical requirement for research involving human subjects. Studies assessing the validity of informed consent and determinants of its quality have highlighted problems in consent delivery and comprehension by trial participants. We report the findings of a questionnaire-based survey conducted to understand the quality of informed consent (QuIC) in cancer clinical trials.
Methods
The survey was conducted in a single tertiary care cancer centre in India. Patients enrolled in phase 1, 2 or 3 interventional studies were administered the QuIC questionnaire by a trained study coordinator. The QuIC, expressed as knowledge score, was calculated from the proportion of correct responses expressed as a percentage.
Results
The mean (SD) knowledge score was 60.46% (1 5.21%). It was considerably higher in industry-sponsored trials compared to investigator-initiated trials (65.32% v. 52.21%, respectively; p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Clinical Pharmacology, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Sector 22, Kharghar, Mumbai 410210, Maharashtra, India.
- Public Health Research Centre, New York University, Abu Dhabi, United Arab Emirates.
Zitieren
APA
Gota, V., Nookala, M., Yadav, A., Menezes, S. R., Kannan, S., & Ali, R. (2018). Quality of informed consent in cancer clinical trials in India: A cross-sectional survey. The National Medical Journal of India, 31(6), 334. https://doi.org/10.4103/0970-258x.262900
Vancouver
Gota V, Nookala M, Yadav A, Menezes SR, Kannan S, Ali R. Quality of informed consent in cancer clinical trials in India: A cross-sectional survey. The National Medical Journal of India. 2018;31(6):334. doi:10.4103/0970-258x.262900
BibTeX
@article{Gota2018,
author = {Gota, Vikram and Nookala, Manjunath and Yadav, Akanksha and Menezes, Sonia Rebecca and Kannan, Sadhana and Ali, Raghib},
title = {Quality of informed consent in cancer clinical trials in India: A cross-sectional survey},
journal = {The National Medical Journal of India},
year = {2018},
volume = {31},
number = {6},
pages = {334},
doi = {10.4103/0970-258x.262900}
}
EUVIMED